2025-2026 Regular Session • New York Legislature
S07297
Legislative Summary
Relates to utilization review program standards; requires use of evidence-based and peer reviewed clinical review criteria; relates to prescription drug formulary changes and pre-authorization for certain health care services.
Demographic Impact
Overall analysis of equity impact
80% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
4/9/2025
REFERRED TO HEALTH
Senate
Status Information
Current Status
Introduced(4/9/2025)
Chamber
Senate
Committee
Health(Senate)
Sponsors
Democrat: 11
Republican: 2
Primary Sponsor
Brad Hoylman-Sigal
Democrat